TY - JOUR
T1 - New biomedical approaches for sexually transmitted infection prevention
T2 - Vaccines and microbicides
AU - Rupp, Richard
AU - Stanberry, Lawrence R.
AU - Rosenthal, Susan L.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/6
Y1 - 2004/6
N2 - STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.
AB - STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.
UR - http://www.scopus.com/inward/record.url?scp=3142634642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142634642&partnerID=8YFLogxK
U2 - 10.1016/j.admecli.2004.02.010
DO - 10.1016/j.admecli.2004.02.010
M3 - Review article
C2 - 15449851
AN - SCOPUS:3142634642
SN - 1547-3368
VL - 15
SP - 393
EP - 407
JO - Adolescent Medicine Clinics
JF - Adolescent Medicine Clinics
IS - 2
ER -